OCR 68.12 Omnicare $OCR Hit a 52 week high of 68.48

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 12:40 PM

OCR 68.12 Omnicare $OCR Hit a 52 week high of 68.48 Currently at 68.12 +0.15 +0.22% With a day low of 67.92 and a total volume of 30,050.

OCR Omnicare Recent Headline News

Omnicare Announces Pricing of Senior Notes Offering
Thomson Reuters ONE - Thu Nov 06, 4:41PM CST
CINCINNATI, November 6, 2014 - Omnicare, Inc. (NYSE: OCR) (the "Company"

announced today that it has priced its public offering of $400 million aggregate principal amount of 4.75% Senior Notes due 2022 (the "2022 Notes"

at 100% of principal amount, and $300 million aggregate principal amount of 5.00% Senior Notes due 2024 (the "2024 Notes" and, together with the 2022 Notes, the "Notes"

at 100% of principal amount. The sale of the Notes is expected to close on November 21, 2014, subject to customary closing conditions.
OCR: 68.81 (+0.84)

Omnicare to Present at the Credit Suisse 2014 Health Care Conference
Thomson Reuters ONE - Thu Nov 06, 7:01AM CST
CINCINNATI, November 6, 2014 - Omnicare, Inc. (NYSE:OCR) today announced that it will present at the Credit Suisse Health Care Conference on Tuesday, November 11, 2014 at 3:30 p.m. MST (5:30 p.m. ET) in Phoenix, Arizona.
OCR: 68.81 (+0.84)

Omnicare Set to Possibly Pullback After Yesterday's Rally of 1.67%
Comtex SmarTrend(R) - Wed Nov 05, 5:15PM CST
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $67.53 to a high of $68.55. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $67.31 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OCR: 68.81 (+0.84)

Omnicare Announces Public Offering of Senior Notes
Thomson Reuters ONE - Wed Nov 05, 7:31AM CST
CINCINNATI, November 5, 2014 - Omnicare, Inc. (NYSE: OCR) (the "Company"

announced today that it plans to offer $700 million aggregate principal amount of senior notes due 2022 and senior notes due 2024 in an underwritten public offering.
OCR: 68.81 (+0.84)

Omnicare Specialty Care Group to Provide Specialty Support Services for New Treatment for IPF - OFEV (nintedanib)
Thomson Reuters ONE - Tue Nov 04, 6:30AM CST
CINCINNATI, November 4, 2014 - RxCrossroads and Advanced Care Scripts (ACS), both divisions of Omnicare Specialty Care Group (SCG), announced today that they have been selected to provide services for patients prescribed Boehringer Ingelheim's OFEV(R) capsules (nintedanib).
OCR: 68.81 (+0.84)

Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest
Thomson Reuters ONE - Wed Oct 29, 4:31PM CDT
CINCINNATI, October 29, 2014 - Omnicare, Inc. (NYSE: OCR) announced today that for the period from September 15, 2014 to December 14, 2014 its Series A and Series B Trust Preferred Income Equity Redeemable Securities (NYSE: OCR.PRA and OCR.PRB) (the "Trust PIERS"

will, subject to the terms of the Trust PIERS, accrue contingent interest at a rate of 0.125% of the average trading price of the Trust PIERS for the five trading days ended September 11, 2014, in addition to the continued accrual of regular cash interest.
OCR: 68.81 (+0.84)

Health Care Services Stocks Highlight - Express Scripts Holding, Omnicare, MEDNAX, DaVita HealthCare Partners, and Quest Diagnostics
PR Newswire - Wed Oct 29, 8:05AM CDT
Investor-Edge has initiated coverage on the following equities: Express Scripts Holding Co. (NASDAQ: ESRX), Omnicare Inc. (NYSE: OCR), MEDNAX Inc. (NYSE: MD), DaVita HealthCare Partners Inc. (NYSE: DVA), and Quest Diagnostics Inc. (NYSE: DGX). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 760.91, up 0.74%, with the index advancing 6.21% in the previous three months. Register for your complimentary reports on these five stocks at:
OCR: 68.81 (+0.84), ESRX: 77.82 (-0.05), DVA: 74.50 (+0.01), DGX: 62.76 (+1.07), MD: 62.32 (+0.14)

Omnicare Beats on Q3 Earnings and Sales, Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 11:40AM CDT
Omnicare Inc. (OCR) reported better-than-expected third quarter 2014 results.
PMC: 25.20 (-0.34), OCR: 68.81 (+0.84), CRL: 63.96 (+0.60), ICLR: 53.21 (+0.60)

Look for Shares of Omnicare to Potentially Pullback after Yesterday's 3.70% Rise
Comtex SmarTrend(R) - Fri Oct 24, 5:17PM CDT
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $64.31 to a high of $67.66. Yesterday, the shares gained 3.7%, which took the trading range above the 3-day high of $65.24 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OCR: 68.81 (+0.84)

Omnicare tops 3Q profit forecasts
Automated Insights - Fri Oct 24, 6:48AM CDT
CINCINNATI (AP) _ Omnicare Inc. (OCR) on Friday reported third-quarter net income of $64.8 million.
OCR: 68.81 (+0.84)

Omnicare Reports Third-Quarter 2014 Financial Results; Company Updates Full-Year 2014 Guidance
Thomson Reuters ONE - Fri Oct 24, 6:16AM CDT
CINCINNATI, October 24, 2014 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its third quarter ended September 30, 2014.
OCR: 68.81 (+0.84)

Omnicare Larger Than S&P 500 Component News Corp NWSA
TheOnlineInvestor.com - Tue Oct 07, 3:51PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Omnicare Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example News Corp , according to The Online...
OCR: 68.81 (+0.84)

'Mad Money' Lightning Round: Buy, Buy, Buy Kohlberg Kravis Roberts
at The Street - Sat Oct 04, 5:00AM CDT
Cramer likes McKesson and Corning but isn't recommending Sanchez Energy.
KNDI: 16.43 (-0.67), VIPS: 24.39 (+1.05), OCR: 68.81 (+0.84), MCK: 201.15 (+1.83), SN: 17.06 (-0.32), KKR: 21.76 (+0.37), GLW: 20.76 (+0.21), AAPL: 108.94 (-0.07), FI: 19.01 (-0.31), BABA: 117.28 (+2.72)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Oct 03, 7:09PM CDT
The U.S. is stronger than we thought, Cramer says, but will it last?
KSS: 57.11 (-0.11), VIPS: 24.38 (+1.04), OCR: 68.81 (+0.84), UTX: 108.93 (-0.15), TKMR: 16.01 (-0.74), BBY: 34.75 (-0.43), KKR: 21.76 (+0.37), ADBE: 71.73 (+0.13), FAST: 44.53 (unch), COST: 137.46 (-0.25), PNC: 88.43 (-0.02), AAPL: 108.94 (-0.07), MBLY: 46.29 (-0.48), FI: 19.01 (-0.31), KNDI: 16.43 (-0.67), MCK: 201.15 (+1.83), FB: 74.96 (-0.64), LNG: 72.23 (+0.28), SN: 17.06 (-0.32), TCS: 20.57 (-1.36), GLW: 20.76 (+0.21), FDO: 78.56 (-0.28), CELG: 107.49 (+1.04), MHR: 4.71 (+0.02), ISIS: 46.16 (+1.57), BABA: 117.28 (+2.72)

Omnicare to Report Third-Quarter 2014 Financial Results and Hold Conference Call on Friday, October 24, 2014
Thomson Reuters ONE - Wed Oct 01, 6:00AM CDT
CINCINNATI, October 1, 2014 - Omnicare, Inc. (NYSE:OCR) will release its financial results for the third-quarter of fiscal 2014 before the market opens on Friday, October 24, 2014.
OCR: 68.81 (+0.84)

Jeffrey W. Ubben, CEO Of ValueAct Capital, Appointed To The Board Of Valeant Pharmaceuticals
CNW Group - Thu Sep 25, 7:00AM CDT
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that its Board of Directors has appointed Jeffrey W. Ubben, Founder, Chief Executive Officer, and the Chief Investment Officer of ValueAct Capital, as a director of the Board, effective as of October 1, 2014.
VRX: 127.34 (+1.23), OCR: 68.81 (+0.84), PSTI: 2.68 (+0.02), WSH: 42.20 (+0.22), MSO: 4.14 (+0.09), IT: 84.12 (+0.58), ACXM: 19.10 (+0.04), VRX.TO: 144.50 (+1.66)

GMT, OCR, NSC, ABG, LMT, PPG Expected To Be Up Before Next Earnings Releases
M2 - Wed Sep 24, 3:40AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and December earnings reports. GATX Corp (NYSE:GMT), Omnicare Inc (NYSE:OCR), NORFOLK SOUTHERN CORPORATION (NYSE:NSC), Asbury Automotive Group Inc (NYSE:ABG), Lockheed Martin Corp (NYSE:LMT), PPG Industries Inc (NYSE

PG) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Thursday:
LMT: 186.97 (+0.82), NSC: 115.97 (+3.11), OCR: 68.81 (+0.84), GMT: 65.57 (+0.46), ABG: 72.65 (-0.98), PPG: 207.13 (+0.23)

Omnicare (OCR) Is Today's Roof Leaker Stock
at The Street - Tue Sep 23, 9:01AM CDT
Trade-Ideas LLC identified Omnicare (OCR) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
OCR: 68.81 (+0.84)

Ashok Singh to Join Omnicare as SVP, Chief Information Officer
Thomson Reuters ONE - Mon Sep 22, 6:01AM CDT
CINCINNATI, September 22, 2014 - Omnicare, Inc. (NYSE: OCR) today announced Ashok Singh has been appointed Senior Vice President, Chief Information Officer (CIO) effective October 1, 2014.
OCR: 68.81 (+0.84)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ATTACK SHARK Partners with Cloud9 League Team

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Media Forum Spotlights Asia-Pacific Cooperation

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Park Systems Expands in the Pacific Northwest

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Changhong's IFA 2026 Showcase: AI, Culture & Localization

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Clover's RSV Combo Vaccine Shows Promise in Trials

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

ISO 45010: First Guidance for Menstruation, Menopause

Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Rznomics Unveils Breakthrough in Circular RNA Production

Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...